etodolac has been researched along with Coxarthrosis in 4 studies
Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of etodolac (600 mg/day) and placebo were compared in a 4-week double-blind, parallel-group study involving 104 patients with osteoarthritis of the knee and 106 with osteoarthritis of the hip." | 9.06 | Etodolac therapy for osteoarthritis: a double-blind, placebo-controlled trial. ( Hosie, J; Scott, DL; Williams, PI, 1989) |
| "An open clinical trial was carried out in 57 patients with osteoarthritis of the knee, hip or spine to assess the effectiveness and tolerability of etodolac." | 7.67 | Efficacy and tolerability of etodolac in the treatment of osteoarthritis. ( Ciocci, A, 1989) |
| "The efficacy of etodolac (600 mg/day) and placebo were compared in a 4-week double-blind, parallel-group study involving 104 patients with osteoarthritis of the knee and 106 with osteoarthritis of the hip." | 5.06 | Etodolac therapy for osteoarthritis: a double-blind, placebo-controlled trial. ( Hosie, J; Scott, DL; Williams, PI, 1989) |
| "An open clinical trial was carried out in 57 patients with osteoarthritis of the knee, hip or spine to assess the effectiveness and tolerability of etodolac." | 3.67 | Efficacy and tolerability of etodolac in the treatment of osteoarthritis. ( Ciocci, A, 1989) |
| " Improvement in force transmission was dosage dependent for the primary outcome measurement (vertical impulse)." | 2.69 | Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs. ( Budsberg, SC; Claxton, R; DeCamp, CE; Johnston, SA; Schwarz, PD, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Budsberg, SC | 1 |
| Johnston, SA | 1 |
| Schwarz, PD | 1 |
| DeCamp, CE | 1 |
| Claxton, R | 1 |
| Mejjad, O | 1 |
| Favre, S | 1 |
| Dujardin, F | 1 |
| Thomine, J | 1 |
| Le Loët, X | 1 |
| Weber, J | 1 |
| Williams, PI | 1 |
| Hosie, J | 1 |
| Scott, DL | 1 |
| Ciocci, A | 1 |
3 trials available for etodolac and Coxarthrosis
| Article | Year |
|---|---|
Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Dog Diseases; Dogs; Dos | 1999 |
Efficacy of etodolac on gait in hip osteoarthritis as assessed by Bessou's locometer: a randomized, crossover, double-blind study versus placebo. Groupe de Recherche sur le Handicap de L'appareil Locomoteur.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Double-Blind Method; Etodo | 2000 |
Etodolac therapy for osteoarthritis: a double-blind, placebo-controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Double-Blind Method; | 1989 |
1 other study available for etodolac and Coxarthrosis
| Article | Year |
|---|---|
Efficacy and tolerability of etodolac in the treatment of osteoarthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Etodolac; Female; Humans; Indoleacetic Acids; | 1989 |